4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-22-049960
Director sold 21,267 shares at $3.61 ($76,774)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| EASTHAM KARIN Director | 2022-09-13 | Sale | −21,267 | $3.61 | $76,774 | 13,033 | D |
| Open-market sales · 21,267 sh · avg $3.61 · $76,774 | |||||||
Loading xslF345X03/doc4.xml…